Idiopathic copper-associated cirrhosis

Idiopathic copper-associated cirrhosis (also known as idiopathic copper toxicosis or non-Indian childhood cirrhosis) is an extremely rare liver disease characterized by the abnormal accumulation of copper in the liver, leading to progressive liver damage and cirrhosis. Unlike Wilson disease, this condition is not associated with mutations in the ATP7B gene, and unlike Indian childhood cirrhosis, it occurs outside the Indian subcontinent. The disease primarily affects the hepatic system, with excessive copper deposition in hepatocytes causing oxidative damage, inflammation, hepatocellular necrosis, and ultimately cirrhosis. Key clinical features include hepatomegaly (enlarged liver), jaundice, failure to thrive, and signs of progressive liver failure. The condition typically presents in early childhood, and affected children may develop ascites, portal hypertension, and coagulopathy as the disease advances. Liver biopsy reveals markedly elevated hepatic copper concentrations with characteristic histological findings including pericellular fibrosis, hepatocyte necrosis, and Mallory-Denk bodies. The etiology remains unclear, though both genetic susceptibility and environmental factors (such as elevated copper intake from contaminated water or copper vessels) have been proposed as contributing factors. Treatment approaches include copper chelation therapy (such as D-penicillamine or trientine) aimed at reducing hepatic copper burden, and dietary restriction of copper intake. In cases of advanced cirrhosis unresponsive to medical management, liver transplantation may be necessary. Early diagnosis and initiation of chelation therapy may improve outcomes, though the prognosis can be poor if the disease is diagnosed at an advanced stage.

Common questions about Idiopathic copper-associated cirrhosis